$BCLI BRAINSTORM CELL THERAPEUTICS INC. Insider Trading

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

CIK Number: 0001137883
IRS Number: 207273918
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: BCLI
Company Address: 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK 10019
Phone number: 201-488-0460
Former name: WIZBANG TECHNOLOGIES INC, date of change: 2001-04-09
Former name: GOLDEN HAND RESOURCES INC, date of change: 2003-08-27
Former name: BRAINSTORM CELL THERAPEUTICS INC, date of change: 2004-11-22

Brainstorm Cell Therapeutics, Inc. is a biotechnology company, which develops and commercializes autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis, Progressive Multiple Sclerosis, Alzheimer’s disease, and other neurodegenerative diseases. Its pipeline, NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and improve neurological function. The company was founded by Irit Arbel on September 22, 2000 and is headquartered in New York, NY.

Market Capitalization: $60.17M
Prev close: $3.22
Average Daily Volume: 215,132
Days Low: $3.17
Year Low: $2.06
Year High: $3.87

BRAINSTORM CELL THERAPEUTICS INC. Latest Insider Transactions

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Dec 31 2020	BCLI	BRAINSTORM CELL TH ...	Shah Preetam	EVP, CFO and Treasu ...	Payment of Exercise	F	4.64	25,000	116,000	11,600	36.6 K to 11.6 K (-68.31 %)
Dec 31 2020	BCLI	BRAINSTORM CELL TH ...	Shah Preetam	EVP, CFO and Treasu ...	Payment of Exercise	F	4.64	25,000	116,000	11,600	36.6 K to 11.6 K (-68.31 %)
Nov 19 2020	BCLI	BRAINSTORM CELL TH ...	Lindborg Stacy	EVP, Head Global Cl ...	Option Exercise	P	10.00	200	2,000	200
Sep 10 2020	BCLI	BRAINSTORM CELL TH ...	Waclawski Anthony	See Remarks	Option Exercise	A	12.58	80,000	1,006,400	80,000
Sep 10 2020	BCLI	BRAINSTORM CELL TH ...	Waclawski Anthony	See Remarks	Grant	A	0.00	35,000	0	35,000	0 to 35 K
Jul 31 2020	BCLI	BRAINSTORM CELL TH ...	Lebovits Chaim	Chief Executive Off ...	Grant	A	0.00	31,185	0	124,740	93.6 K to 124.7 K (+33.33 %)
Jul 16 2020	BCLI	BRAINSTORM CELL TH ...	Abbhi Sankesh	Director	Buy	P	12.99	46,779	607,659	2,164,530	2.1 M to 2.2 M (+2.21 %)
Jul 16 2020	BCLI	BRAINSTORM CELL TH ...	Setboun David	EVP and COO	Buy	P	12.95	5,000	64,740	55,000	50 K to 55 K (+10.00 %)
Jul 16 2020	BCLI	BRAINSTORM CELL TH ...	ACC International Holdings Ltd ...		Sell	S	13.47	7,823	105,351	67,053	74.9 K to 67.1 K (-10.45 %)
Jul 16 2020	BCLI	BRAINSTORM CELL TH ...	ACC International Holdings Ltd ...		Sell	S	13.12	18,430	241,715	74,876	93.3 K to 74.9 K (-19.75 %)
Jul 16 2020	BCLI	BRAINSTORM CELL TH ...	ACC International Holdings Ltd ...		Sell	S	13.52	40,000	540,952	93,306	133.3 K to 93.3 K (-30.01 %)
Jul 16 2020	BCLI	BRAINSTORM CELL TH ...	ACC International Holdings Ltd ...		Sell	S	13.35	2,000	26,700	133,306	135.3 K to 133.3 K (-1.48 %)
Jul 16 2020	BCLI	BRAINSTORM CELL TH ...	ACC International Holdings Ltd ...		Sell	S	13.13	3,500	45,939	135,306	138.8 K to 135.3 K (-2.52 %)
Jun 26 2020	BCLI	BRAINSTORM CELL TH ...	Yablonka Uri	EVP & Chief Busines ...	Grant	A	0.00	10,000	0	17,543	7.5 K to 17.5 K (+132.57 %)
Jun 01 2020	BCLI	BRAINSTORM CELL TH ...	Lindborg Stacy	EVP, Head Global Cl ...	Option Exercise	A	7.67	100,000	767,000	100,000

View all BRAINSTORM CELL THERAPEUTICS INC. insider transactions.